For example, a meta-analysis revealed significantly lower circulating adiponectin concentrations in patients who later developed prostate cancer than in control subjects, suggesting adiponectin as a promising biomarker for early detection of prostate cancer [110]. Here, ADIPOQ is linked to Familial prostate cancer.